Teva Swings to Loss, But Beats Expectations

Teva Pharmaceuticals swung to a loss on an acquisition write-down, as its interim CEO contends with a deal-driven debt load, though shares rose as the company beat revenue and profit expectations.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news